Suppr超能文献

系统性红斑狼疮患者成功妊娠的安全性问题及相关建议。

Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus.

机构信息

Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, CA, USA.

Division of Rheumatology and Clinical Immunology, Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Science and Translational Medicine, University of Milan, Italy.

出版信息

J Autoimmun. 2018 Sep;93:16-23. doi: 10.1016/j.jaut.2018.07.016. Epub 2018 Jul 27.

Abstract

Systemic lupus erythematosus (SLE) primarily affects women of childbearing age. One of the major changes in SLE focuses on the timing of a successful pregnancy. In the past, pregnancy was strongly discouraged in SLE, especially in the presence of risk factors such as nephritis, use of immunosuppressive therapies, or positivity of specific autoantibodies such as anti-phospholipids and anti-Ro/SSA, La/SSBA. Thanks to our better knowledge on the disease and management, pregnancy success rates in SLE patients have significantly improved care by the a multidisciplinary team which fosters a successful pregnancy with minimal complications for the mother and fetus when the disease is inactive or in remission. This approach is based on a counseling phase before pregnancy, to assess SLE activity phase, specific medications, risk factors, and continues through pregnancy and lactation with significantly improved pregnancy outcomes. Further, we can now better define the risk of disease flares during pregnancy based on a better understanding of the changes in maternal immunity and its relationship with SLE-associated autoimmunity and chronic inflammation. There is wide consensus that women with SLE can have successful pregnancies as long as conception is planned in a phase of inactive disease, and when the patient is closely managed by a rheumatologist, high-risk OB/GYN, neonatologist, and other medical specialists as indicated. Preconception counseling is essential to assess the risk of both fetal and maternal complications as well as identify life-threatening contraindications. Particular attention should be used in those SLE cases that have nephritis, APS or positivity for aPL, pulmonary hypertension, and positive anti-Ro/SSA or anti-La/SSB antibodies. In conclusion, the use of specific guidelines on the management of SLE before and during pregnancy and lactation, and a better understanding of the use of immunosuppressive therapies have significantly increased pregnancy success.

摘要

系统性红斑狼疮(SLE)主要影响育龄妇女。SLE 的主要变化之一集中在成功妊娠的时机上。过去,SLE 强烈不鼓励妊娠,尤其是存在肾炎、免疫抑制治疗、或特定自身抗体如抗磷脂和抗 Ro/SSA、La/SSBA 阳性等危险因素时。由于我们对疾病和管理的认识提高,SLE 患者的妊娠成功率显著提高,多学科团队的护理促进了成功妊娠,使母亲和胎儿的并发症最小化,前提是疾病处于不活动或缓解期。这种方法基于妊娠前的咨询阶段,评估 SLE 活动期、特定药物、危险因素,并贯穿整个妊娠和哺乳期,妊娠结局显著改善。此外,我们现在可以更好地根据母体免疫变化及其与 SLE 相关自身免疫和慢性炎症的关系来定义妊娠期间疾病发作的风险。广泛共识认为,只要计划在疾病不活动期受孕,并且由风湿病学家、高危妇产科医生、新生儿科医生和其他医学专家密切管理患者,SLE 女性可以成功妊娠。孕前咨询对于评估胎儿和母亲并发症的风险以及确定危及生命的禁忌证至关重要。特别注意那些有肾炎、APS 或 aPL 阳性、肺动脉高压以及阳性抗 Ro/SSA 或抗 La/SSB 抗体的 SLE 病例。总之,在妊娠前和妊娠期间及哺乳期使用关于 SLE 管理的具体指南,以及更好地理解免疫抑制治疗的应用,显著提高了妊娠成功率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验